Megan Knight
Investor Relations Kontakt bei ARENA PHARMACEUTICALS
Profil
Megan E.
Knight is currently the Director-Investor Relations at Arena Pharmaceuticals, Inc. and the Vice President & Head-Investor Relations at Longboard Pharmaceuticals, Inc. She previously worked as the Head-Investor Relations & Corporate Communications at Senomyx, Inc.
Aktive Positionen von Megan Knight
| Unternehmen | Position | Beginn |
|---|---|---|
| ARENA PHARMACEUTICALS | Investor Relations Kontakt | - |
| LONGBOARD PHARMACEUTICALS, INC. | Investor Relations Kontakt | 01.01.2021 |
Ehemalige bekannte Positionen von Megan Knight
| Unternehmen | Position | Ende |
|---|---|---|
| SENOMYX INC. | Investor Relations Kontakt | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LONGBOARD PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Senomyx, Inc.
 Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Senomyx, Inc. engages in the development and commercialization of flavor ingredients for the packaged food, beverage, and ingredient supply industries. It develops high intensity sweeteners, savory flavors, bitter taste blockers, and cooling agents. The company was founded by Paul A. Grayson, Lubert Stryer, Yon Chien Tsien, Denis Baylor, Harold McGee, and Charles Zuker on September 16, 1998 and is headquartered in San Diego, CA. | Consumer Non-Durables |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
